BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32712767)

  • 1. Neuroendocrine breast carcinoma: a rare but challenging entity.
    Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M
    Med Oncol; 2020 Jul; 37(8):70. PubMed ID: 32712767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.
    Bogina G; Munari E; Brunelli M; Bortesi L; Marconi M; Sommaggio M; Lunardi G; Gori S; Massocco A; Pegoraro MC; Zamboni G
    Histopathology; 2016 Feb; 68(3):422-32. PubMed ID: 26114478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
    Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G
    Semin Diagn Pathol; 2010 Feb; 27(1):69-76. PubMed ID: 20306832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
    Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
    Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of multicentric low-grade neuroendocrine breast tumor with an unusual histological pattern.
    D'Antonio A; Addesso M; Memoli D; Cascone A; Cremone L
    Breast Dis; 2016; 36(4):161-164. PubMed ID: 27802189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
    Kelten Talu C; Savli TC; Huq GE; Leblebici C
    Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study.
    Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
    BMC Cancer; 2017 Jan; 17(1):72. PubMed ID: 28118820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer.
    Terlević R; Perić Balja M; Tomas D; Skenderi F; Krušlin B; Vranic S; Demirović A
    Ann Diagn Pathol; 2019 Feb; 38():62-66. PubMed ID: 30476894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
    Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases.
    Kelten Talu C; Leblebici C; Kilicaslan Ozturk T; Hacihasanoglu E; Baykal Koca S; Gucin Z
    Ann Diagn Pathol; 2018 Jun; 34():122-130. PubMed ID: 29661717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine Tumors of the Breast.
    Rosen LE; Gattuso P
    Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy.
    Zhu Y; Li Q; Gao J; He Z; Sun R; Shen G; Zhang H; Xia W; Xu J
    Breast J; 2013; 19(4):382-7. PubMed ID: 23721399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine breast cancer: retrospective analysis of 96 patients and review of literature.
    Rovera F; Lavazza M; La Rosa S; Fachinetti A; Chiappa C; Marelli M; Sessa F; Giardina G; Gueli R; Dionigi G; Rausei S; Boni L; Dionigi R
    Int J Surg; 2013; 11 Suppl 1():S79-83. PubMed ID: 24380560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
    Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
    J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary neuroendocrine carcinomas of the breast and neuroendocrine differentiated breast cancers: Relationship between histopathological and radiological features.
    Kayadibi Y; Erginoz E; Cavus GH; Kurt SA; Ozturk T; Velidedeoglu M
    Eur J Radiol; 2022 Feb; 147():110148. PubMed ID: 35007984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroendocrine tumors of the breast: Myth or reality? A systematic review].
    Cheymol C; Abramovici O; Do Cao C; Dumont A; Robin YM; El Hajbi F; Dansin E; Bonneterre J; Lauridant G
    Bull Cancer; 2018 Apr; 105(4):431-439. PubMed ID: 29567279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine Cancer of the Breast: A Rare Entity.
    Irelli A; Sirufo MM; Morelli L; D'Ugo C; Ginaldi L; De Martinis M
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32414120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine needle aspiration cytology of neuroendocrine carcinoma of the breast--a case report and review of literature.
    Kadir AA; Iyengar KR; Peh SC; Yip CH
    Malays J Pathol; 2008 Jun; 30(1):57-61. PubMed ID: 19108413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.
    Lavigne M; Menet E; Tille JC; Lae M; Fuhrmann L; Bonneau C; Deniziaut G; Melaabi S; Ng CCK; Marchiò C; Rouzier R; Bièche I; Vincent-Salomon A
    Mod Pathol; 2018 Jan; 31(1):68-82. PubMed ID: 28884749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.
    Inno A; Bogina G; Turazza M; Bortesi L; Duranti S; Massocco A; Zamboni G; Carbognin G; Alongi F; Salgarello M; Gori S
    Oncologist; 2016 Jan; 21(1):28-32. PubMed ID: 26659223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.